Clinical Trials Logo

Clinical Trial Summary

assessing the role of neuromuscular ultrasound in optic nerve involvement in systemic lupus patients.


Clinical Trial Description

Evaluating the role of neuromuscular ultrasound in optic nerve involvement in systemic lupus patients.by measuring the diameter of optic nerve at certain site and comparing it to healthy subjects measurements and to asses NMUS ability to detect optic neuropathy in lupus patients in comparison to conventional techniques including opthalmologist evaluation and visual evoked potential ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05853003
Study type Observational
Source Assiut University
Contact
Status Completed
Phase
Start date January 1, 2022
Completion date April 30, 2023

See also
  Status Clinical Trial Phase
Terminated NCT02982499 - Biomechanics of Optic Neuropathy
Recruiting NCT05543018 - Effect of Intraocular Tamponade on Visual Perception N/A
Completed NCT03318549 - BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases N/A
Terminated NCT03536559 - Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis Phase 2
Recruiting NCT06128720 - Hyperbaric Oxygen Therapy for Optic Neuropathies N/A
Withdrawn NCT01331616 - Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab Early Phase 1
Not yet recruiting NCT05747781 - STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient N/A
Completed NCT01166594 - Use of Bevacizumab in Trabeculectomy Surgery Phase 4
Completed NCT03268681 - BIOtinidase Test In Optic-Neuropathy
Completed NCT02612571 - Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players N/A
Recruiting NCT03011541 - Stem Cell Ophthalmology Treatment Study II N/A
Enrolling by invitation NCT03760055 - Assessment of Visual Function With a Portable Brain-computer Interface
Recruiting NCT02638714 - Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells Phase 1/Phase 2
Completed NCT04469777 - Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy Phase 1/Phase 2